Use of Vitamin E and C Supplements for the Prevention of Cognitive Decline

Annals of Pharmacotherapy

Volumn 51, Issue 2, 2017, Pages 118-124

  Basambombo, Luta Luse ^a   Carmichael, Pierre Hugues ^a   Côté, Sharlène ^b   Laurin, Danielle ^a  

^a LAVAL UNIVERSITY   (Canada)

^b Gouvernement du Quebec   (Canada)

Author keywords

Alzheimer s disease; antioxidants; cognition; elderly; observational study; vitamin supplement

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; NEUROPROTECTIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; NOOTROPIC AGENT; ANTIOXIDANT;

AGED; ALZHEIMER DISEASE; ARTICLE; COGNITIVE DEFECT; COHORT ANALYSIS; DEMENTIA; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; GROUPS BY AGE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUROPROTECTION; PRIORITY JOURNAL; RISK REDUCTION; SELF REPORT; SEX DIFFERENCE; SMOKING; VITAMIN SUPPLEMENTATION; AGING; CANADA; COGNITIVE DYSFUNCTION; DIETARY SUPPLEMENT; DRUG EFFECTS; PROPORTIONAL HAZARDS MODEL; PSYCHOLOGY; QUESTIONNAIRE; RISK FACTOR;

AGED; AGING; ALZHEIMER DISEASE; ANTIOXIDANTS; ASCORBIC ACID; CANADA; COGNITIVE DYSFUNCTION; COHORT STUDIES; DEMENTIA; DIETARY SUPPLEMENTS; FEMALE; HUMANS; MALE; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SURVEYS AND QUESTIONNAIRES; VITAMIN E;

EID: 85008485948     PISSN: 10600280     EISSN: 15426270     Source Type: Journal    
DOI: 10.1177/1060028016673072     Document Type: Article

References (34)

1. Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP., The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement. 2013;9:63-75.e2. doi:10.1016/j.jalz.2012.11.007.
2. Smetanin P, Kobak P, Briante C, Stiff D, Sherman G, Ahmad S., Rising Tide: The Impact of Dementia in Canada 2008 to 2038. North York, ON, Canada: RiskAnalytica; 2009.
3. Ritchie K, Ancelin ML, Beaino E. Retrospective identification and characterization of mild cognitive impairment from a prospective population cohort. Am J Geriatr Psychiatry. 2010;18:692-700.
4. Sperling RA, Aisen PS, Beckett LA. Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:280-292. doi:10.1016/j.jalz.2011.03.003.
5. Engelhart MJ, Geerlings MI, Ruitenberg A. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA. 2002;287:3223-3229.
6. Morris MC, Evans DA, Bienias JL. Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. JAMA. 2002;287:3230-3237.
7. Devore EE, Grodstein F, van Rooij FJ. Dietary antioxidants and long-term risk of dementia. Arch Neurol. 2010;67:819-825.
8. Devore EE, Kang JH, Stampfer MJ, Grodstein F., The association of antioxidants and cognition in the Nurses’ Health Study. Am J Epidemiol. 2013;177:33-41. doi:10.1093/aje/kws202.
9. Commenges D, Scotet V, Renaud S, Jacqmin-Gadda H, Barberger-Gateau P, Dartigues JF., Eur J Epidemiol. 2000;16:357-363.
10. Grodstein F, Chen J, Willett WC., High-dose antioxidant supplements and cognitive function in community-dwelling elderly women. Am J Clin Nutr. 2003;77:975-984.
11. Zandi PP, Anthony JC, Khachaturian AS. Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study. Arch Neurol. 2004;61:82-88.
12. Fotuhi M, Zandi PP, Hayden KM. Better cognitive performance in elderly taking antioxidant vitamins E and C supplements in combination with nonsteroidal anti-inflammatory drugs: The Cache County Study. Alzheimers Dement. 2008;4:223-227. doi:10.1016/j.jalz.2008.01.004.
13. Masaki KH, Losonczy KG, Izmirlian G. Association of vitamin E and C supplement use with cognitive function and dementia in elderly men. Neurology. 2000;54:1265-1272.
14. Laurin D, Foley DJ, Masaki KH, White LR, Launer LJ., Vitamin E and C supplements and risk of dementia. JAMA. 2002;288:2266-2268.
15. Sano M, Ernesto C, Thomas RG. A controlled trial of selegeline, alpha-tocopherol, or both as treatment for Alzheimer’s disease: The Alzheimer’s Disease Cooperative Study. New Engl J Med. 1997;336:1216-1222.
16. Petersen RC, Thomas RG, Grundman M. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med. 2005;353:951-952.
17. Maxwell CJ, Hicks MS, Hogan DB, Basran J, Ebly EM., Supplemental use of antioxidant vitamins and subsequent risk of cognitive decline and dementia. Dement Geriatr Cogn Disord. 2005;20:45-51.
18. Lindsay J, Sykes E, McDowell I, Verreault R, Laurin D., More than the epidemiology of Alzheimer’s disease: contributions of the Canadian Study of Health and Aging. Can J Psychiatry. 2004;49:83-91.
19. Teng EL, Chui HC., The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry. 1987;48:314-318.
20. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd rev ed. Washington, DC: American Psychiatric Association; 1987.
21. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM., Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology 1984;34:939-944.
22. World Health Organization. Mental and behavioural disorders and developmental disorders. In: Clinical Descriptions and Diagnostic Guidelines (MNH/MEP/87.1 rev 1). Geneva, Switzerland: World Health Organization; 1987:chap 5.
23. Laurin D, Verreault R, Lindsay J, MacPherson K, Rockwood K., Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch Neurol. 2001;58:498-504.
24. Côté S, Carmichael PH, Verreault R, Lindsay J, Lefebvre J, Laurin D., Nonsteroidal anti-inflammatory drug use and the risk of cognitive impairment and Alzheimer’s disease. Alzheimers Dement. 2012;8:219-226. doi:10.1016/j.jalz.2011.03.012.
25. Lin D, Wei L, Ying Z., Checking the Cox model with cumulative sums of Martingale-based residuals. Biometrika. 1993;80:557-572.
26. Morris MC, Beckett LA, Scherr PA. Vitamin E and vitamin C supplement use and risk of incident Alzheimer disease. Alzheimer Dis Assoc Disord. 1998;12:121-126.
27. Luchsinger JA, Tang MX, Shea S, Mayeux R., Antioxidant vitamin intake and risk of Alzheimer disease. Arch Neurol. 2003;60:203-208.
28. Gray SL, Anderson ML, Crane PK. Antioxidant vitamin supplement use and risk of dementia or Alzheimer’s disease in older adults. J Am Geriatr Soc. 2008;56:291-295.
29. Nunomura A, Castellani RJ, Zhu X, Moreira PI, Perry G, Smith MA., Involvement of oxidative stress in Alzheimer disease. J Neuropathol Exp Neurol. 2006;65:631-641.
30. Kordower JH, Chu Y, Stebbins GT. Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment. Ann Neurol. 2001;49:202-213.
31. Perkins AJ, Hendrie HC, Callahan CM. Association of antioxidants with memory in a multiethnic elderly sample using the Third National Health and Nutrition Examination Survey. Am J Epidemiol. 1999;150:37-44.
32. Coley N, Andrieu S, Gardette V. Dementia prevention: methodological explanations for inconsistent results. Epidemiol Rev. 2008;30:35-66.
33. Dysken MW, Sano M, Asthana S. Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial. JAMA. 2014;311:33-44. doi:10.1001/jama.2013.282834.
34. Institute of Medicine; Food and Nutrition Board. Dietary Reference Intakes: Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington, DC: National Academies Press; 2000.